The Federal Trade Commission and two state attorneys general filed enforcement actions July 29, 2026 against telehealth company Hims & Hers, alleging it secretly sent patients’ sensitive medical information to Meta, Snap, Google and more than a dozen other advertising platforms. A separate class action lawsuit filed the next day makes similar claims. The FTC action also alleges deceptive billing and subscription practices, including processing charges earlier than advertised and making cancellations difficult.
What Hims & Hers Does
Hims & Hers operates two telehealth platforms (hims.com and forhers.com) where patients answer intake questionnaires to consult with licensed providers about sexual health, hair loss, weight loss, hormone treatments, dermatology and mental health.
How the Tracking Allegedly Worked
Hims installed tracking pixels and software kits inside its websites and apps that reported user activity to third parties. The company controlled exactly which data was transmitted and to whom.
Meta received custom “events” paired with cookies tying the data directly to individual Facebook accounts. Snap obtained scrambled email addresses it could match to Snapchat accounts. Google collected full web addresses revealing which specific health questionnaire a user opened. Analytics firm Amplitude received actual survey answers. More than a dozen additional advertising and data firms obtained similar information.
What Data Was Tracked
The testosterone questionnaire alone contains roughly 35 questions about symptoms, mood, sexual function, drug use and diagnosed conditions (heart disease, diabetes, cancer). Identity verification asks for name, address, date of birth, last four digits of Social Security number and a facial photo or ID copy.
The Privacy Policy Gap
Hims’ own privacy policy states: “We do not use protected information for advertising or marketing.” A privacy notice promises other disclosures “will require your specific written authorization.” The company told customers they are “in charge” of their data.
The lawsuit alleges these public promises were false.
Billing and Cancellation Claims
The FTC also alleges deceptive subscription practices. Hims advertised monthly or quarterly refill schedules but processed charges approximately 10 days earlier than consumers would expect. To cancel before the charge, customers had only a two-day window — making it easy to miss the deadline. The complaint also alleges the company made cancellation itself unreasonably difficult.
Hims’ Response
Hims has publicly denied all allegations. The company says the lawsuit “disregards substantial evidence” provided during the FTC’s nearly three-year investigation and “contorts the law to try to manufacture claims.”
Where It Stands
No settlement has been reached. No claims process exists. No consumer compensation is available at this time.
The class action covers anyone in the United States who used Hims or Hers and whose data was allegedly sent to third parties, with a separate California class estimated to include millions of people.
What This Case Tests
If regulators win, remedies could include refunds, damages, or injunctions. The litigation tests privacy theories about how health information should be protected outside traditional sectoral laws like HIPAA — an emerging priority for federal and state enforcers.
Consumers interested in this case can monitor PACER filings for updates at the U.S. District Court for the Northern District of California.
About This Page
RecallRefunds.com is a consumer information site. We are not a law firm, government agency, or Hims & Hers Health Inc. This page summarizes pending litigation and regulatory allegations. Allegations are not proven facts; they remain subject to court proceedings and investigation. For complete information, consult official complaint filings.
Official Sources
FTC Enforcement Action (3:26-cv-07871):
Class Action Lawsuit (4:26-cv-07941): 3. PACER Case Filing — Doe et al. v. Hims & Hers Health, Inc.